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Abstract
Background: Lyme borreliosis is a common tick-borne disease of the northern hemisphere that is caused by bacterial
spirochaetes of the Borrelia burgdorferi (sensu lato) (Bbsl) complex. To date, there has been no convincing evidence for
locally-acquired Lyme borreliosis on the Australian continent and there is currently a national debate concerning the
nature and distributions of zoonotic tick-transmitted infectious disease in Australia. In studies conducted in Europe and
the United States, dogs have been used as sentinels for tick-associated illness in people since they readily contact ticks
that may harbour zoonotic pathogens. Applying this principle, we used a combination of serological assays to test
dogs living in tick ‘hot spots’ and exposed to the Australian paralysis tick, Ixodes holocyclus, for evidence of exposure to
B. burgdorferi (s.l.) antigens and other vector-borne pathogens.
Results: Altogether, 555 dogs from four demographic groups were recruited into this study. One dog had evidence of
exposure to Anaplasma spp. but no other dog was positive in screening tests. A total of 122 dogs (22.0%) had a kinetic
ELISA (KELA) unit value > 100, and one dog with a high titre (399.9 KELA units) had been vaccinated against B. burgdorferi
(sensu stricto) before travelling to Australia. Older dogs and those with a history of tick paralysis were significantly more likely
to have a KELA unit value > 100. Line immunoassay analysis revealed moderate-to-weak (equivocal) bands in 27 (4.9%) dogs.
Conclusions: Except for a single dog presumed to have been exposed to Anaplasma platys, infection with Anaplasma
spp. B. burgdorferi (s.l.), Ehrlichia spp., and Dirofilaria immitis, was not detected in the cohort of Australian dogs evaluated in
this study. These results provide further evidence that Lyme borreliosis does not exist in Australia but that cross-reacting
antibodies (false positive results) are common and may be caused by the transmission of other tick-associated organisms.
Keywords: Lyme borreliosis, Borrelia burgdorferi (s.l.), Anaplasma, Ehrlichia, Ixodes, Ticks, Vector-borne disease, Serology,
Canine sentinel, Australia
Background
Animals are often the first to come in contact with
microbes, contaminants, and pollutants that can cause ill-
ness in people and the development of clinical signs in
these species can provide early warning for potential threats
to human health. Multiple species of wild and domesticated
animals have been utilised as sentinels of environmental
hazards, including infectious diseases, and serosurveys of
dogs have been widely conducted in North America and
Europe as an adjunct to the surveillance of human Lyme
borreliosis (LB), commonly termed Lyme disease (LD) [1–5].
Dogs are particularly effective sentinels for vector-borne
diseases such as LB since their inquisitive behaviour off lead
takes them into the long grass and shrub land where they
have the potential to come into contact with questing ticks
that harbour pathogens. It has been demonstrated that the
prevalence of antibodies to Borrelia burgdorferi (s.l.) (Bbsl),
the aetiological agents of LB, in endemic areas is significantly
greater in dogs than in people [6]. Seropositivity to the LB
agent was 0.4–25% in dogs tested in south eastern and
mid-Atlantic regions of the USA [7], 8% in dogs in Maine,
USA [2], 1.9–10.3% in Germany [8] and 17–18% amongst
pet and hunting dogs in The Netherlands [1]. Serosurveys
are, however, not without limitations and despite the high
sensitivity and specificity of commercially available diagnos-
tic tests, caution is advised when interpreting results,
especially from convenience samples in low prevalence
populations. Additionally, infection by Bbsl results in a
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lower incidence of clinical illness in dogs than it does in
people [9]. It has been concluded that canine seroprevalence
to Bbsl greater than 5% was a sensitive but non-specific
marker of human risk, whereas seroprevalence less than 1%
was associated with minimal risk of human infection [10].
In Australia, the diagnosis of LB and a so-called ‘Lyme
disease-like syndrome’ has been the subject of much
debate, recently resulting in a parliamentary hearing, a
Senate enquiry, intense media interest, and three pub-
lished reviews [11–14]. To date, except for rickettsiosis
and coxiellosis, there is no convincing evidence for
locally-acquired tick-borne infectious diseases of humans
in Australia. Indeed, none of the recognised tick species
(the ‘ricinus’ complex of Ixodes) responsible for vector-
ing LB and associated pathogens in other parts of the
world occurs in Australia, and in one experimental
study, it was concluded that Australia does not appear
to have a competent vector of Bbsl [15]. Current medical
opinion regarding positive results of screening antibody
tests to Bbsl, and other tick-borne pathogens such as
Anaplasma spp., Ehrlichia spp. and Babesia spp. in
people with no overseas travel is that these most likely
represent false positive serological test results [13].
There has been one previous survey for LB-specific
antibodies in dogs in Australia, conducted in Brisbane,
Queensland over twenty years ago [16]. Although
approximately 40% of these dogs had a history of a tick
bite, all serum samples were negative. Since that time
recombinant purified antigens and peptides derived from
the bacteria, including a Borrelia-specific lipoprotein
VlsE (C6 peptide) have improved the sensitivity of detec-
tion of Bbsl tests while maintaining specificity in both
screening assays and immunoblots. We hypothesised
that dogs living within the geographical regions that
coincide with the majority of the Lyme disease-like
reports in humans (coastal NSW) would offer the
greatest probability of detecting antibodies if LB was en-
demic within the tick populations within those regions.
This cross-sectional canine serosurvey was conducted
primarily to further the search for evidence of Bbsl and
other vector-borne infections within Australia, selecting
dogs considered most at risk should Bbsl be present i.e.
targeted serosurveillance.
Methods
Collection of samples
Between April 2011 and December 2013 dogs were
recruited into this cross-sectional study from four sources
around Australia as described in Table 1 and Fig. 1. Each
dog owner (Groups 1 & 2) completed a questionnaire
Table 1 Group details
Group Number Description and location
1 381 Dogs (multiple breeds) residing in the Northern Beaches local government area of Sydney, New South Wales (NSW)
specifically within postcodes 2101–2108 and 2084 (Fig. 1). This densely populated area of NSW is highly enzootic for
the Australian paralysis tick (Ixodes holocyclus). Numerous cases of tick paralysis in domestic animals are treated by
veterinarians in this area each year and the emergency departments of three local hospitals (Mona Vale, Manly and
Hornsby) collectively treated 1,131 tick bite presentations in humans between July 2014 and August 2016 (Dr Ben
Taylor, Mona Vale Hospital, 2016 pers. com.). Dogs were recruited by advertisement through local veterinary hospitals
and at the Pittwater (now Northern Beaches) Council’s annual event ‘Dog Day by the Bay’ (in 2012 and 2013) at the
Rowland Reserve, Bayview. Dogs in this group represented a cohort considered highly likely to be exposed to I. holocyclus
and therefore act as potential sentinels for human infections.
2 60 Dogs (multiple breeds) owned by and living with people with a variety of symptoms (e.g. headaches, joint and muscle pain,
fatigue, sleeplessness, rash, memory loss, etc.) consistent with a ‘Lyme disease-like syndrome’, who had received a diagnosis of
a tick-associated illness by a medical practitioner. Owners enrolled their dogs following advertisements by patient advocacy
groups and by word of mouth. Dogs assigned to this group were located throughout Australia, but mostly in coastal NSW and
Western Australia. Dogs in this group were chosen because of their close association with humans who had received a diagnosis
and may, therefore, provide selective evidence for a sentinel status.
3 84 Dogs (foxhounds) resident at Northern Serums Pty Ltd, Lismore NSW, an APVMA-approved manufacturer of paralysis
tick antiserum. Most (n = 79) of these dogs were bred within the facility, with five adult dogs sourced originally from
elsewhere, i.e. Brisbane (n = 1) and Melbourne (n = 4). At this facility, approximately 400 unfed (questing) female I.
holocyclus ticks collected from multiple locations in coastal NSW (Lismore North, Casino, Tabulam South, Macksville)
and Queensland (Maleny, Atherton and Bauple Mountain) are attached to each dog annually and allowed to feed
and engorge before removal. Blood is drawn regularly from these dogs for the manufacture of hyperimmune serum
which is supplied commercially to veterinarians for the treatment of tick paralysis in domestic animals. Dogs in this
group were chosen to specifically test the hypothesis that dogs bitten by I. holocyclus are sentinels for certain infections
transmitted by this tick species.
4 30 Dogs (camp dogs; dingo crosses and other breeds) residing at two indigenous communities located on the Dampier
Peninsula, north of Broome in the tropical Kimberley region of Western Australia. These dogs were sampled as part of
routine health assessments and to determine the internal and external parasite load. In this area, there is a high
prevalence of the brown dog tick (Rhipicephalus sanguineus) and minimal ectoparasite control. These dogs served as
a control group since I. holocyclus does not occur in this location.
Total 555
Abbreviations: APVMA Australian Pesticides and Veterinary Medicines Authority, NSW New South Wales
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Fig. 1 Map showing the Northern Beaches area of Sydney, NSW, postcodes 2101–2108 and 2084, selected for sampling dogs in Group 1. (Map credit:
voomMAPS.com)
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soliciting information pertaining to the dog’s age, sex,
breed, postcode of residence, history of ectoparasite (tick
and flea) exposure (including tick paralysis), and travel
history (local, interstate and overseas). Additionally,
personal medical histories were provided by the owners of
dogs in Group 2. Blood samples, collected by veterinar-
ians, were transferred into EDTA-coated and serum
(clot) tubes.
Enzyme immunoassay testing
Whole blood was screened for antibodies to Bbsl,
Anaplasma phagocytophilum, A. platys, Ehrlichia canis
and E. chaffeensis, and for Dirofilaria immitis antigen,
using a rapid enzyme immunoassay (EIA) kit (SNAP® 4Dx
and SNAP® 4Dx Plus, IDEXX Laboratories Inc., Westbrook,
Maine, USA) according to the manufacturer’s instructions.
PCR testing
Positive samples from EIA test protocol were sent (on
dry ice) for PCR analysis to the Vector Borne Disease
Diagnostics Laboratory at North Carolina State University,
Raleigh, USA [17].
ELISA and Line immunoassay
Following centrifugation and separation from blood
cells, serum samples were stored at -20 °C at Murdoch
University until batched and shipped (on ice) to the
Ludwig-Maximilians-University in Munich, Germany,
where they were analysed for Bbsl-specific antibodies,
initially using a computerized kinetic ELISA (KELA) per-
formed as described previously [18]. Briefly, sonicated
whole cell-lysate of culture-derived B. burgdorferi (sensu
stricto) N40 served as antigen. Canine sera were diluted
1:100 in PBS with 0.05% of Tween 20 (AppliChem
GmbH, Darmstadt, Germany) and 2% milk powder
(Merck KGaA, Darmstadt, Germany). Antibodies were
detected with HRP-conjugated goat anti-dog IgG (Cappel
Laboratories, West Chester, PA, USA) in a dilution of
1:2,000 in PBS with Tween 20 and milk powder after the
addition of the TMB substrate system (KPL Inc.,
Gaithersburg, MD, USA). The developing absorbance
of all samples was measured 5 times starting 2 min
after the addition of TMB in 35 s intervals at λ = 650 nm
with a SpectraMax Plus 384 plate reader (Molecular
Devices, LLC., Sunnyvale, CA, USA). The KELA testing
was followed by line immunoassay (LIA) to identify the
probable targets of the antibodies using the Borrelia LIA
(Sekisui Virotech GmbH, Rüsselsheim, Germany). Serum
samples indicative for dogs which might have had contact
with Borrelia organisms were defined as those with KELA
unit value > 100 [18, 19] and two or more bands in the
LIA to the following antigens: VlsE mix, OspA mix
(31 kDa), DpbA mix, OspC mix (23 kDa), BmpA
(39 kDa), p58, p83/100 [19].
Statistical analysis
Data were analysed using SPSS version 21. Categorical
data were analysed with a Chi-square test for independ-
ence and odds ratios (OR) and their 95% confidence inter-
vals (CI) calculated. For the continuous variable (age), an
ANOVA was used to compare dogs with KELA
units > 100 (equivocal to positive) and those < 100 (nega-
tive) after testing for homogeneity of variances and
normality. An association between seropositivity and age,
sex, ectoparasite exposure, history of tick paralysis and
travel was evaluated with P < 0.050 considered significant.
Results
A total of 555 dogs were recruited into this study
(Table 1). During initial screening by EIA, a single dog
in Group 1 (a 5-year-old male Labrador living in Ingle-
side, NSW, 2101) returned a positive result to Anaplasma
spp. antibodies. This dog had a history of tick attachment
and tick paralysis, despite the owner reporting use of ecto-
parasiticides, and had not travelled away from home.
Further analysis of a blood sample from this dog was
negative on PCR for Anaplasma spp. DNA (data not
shown). All other dogs tested were negative for Bbsl,
Anaplasma spp. and Ehrlichia spp. antibodies, and for D.
immitis antigen (Table 2).
Table 2 Enzyme immunoassay serology test results
Organism tested Group 1 Group 2 Group 3 Group 4
Pos Neg Pos Neg Pos Neg Pos Neg
Anaplasma platys/phagocytophilum 1 380 0 60 0 84 0 30
Ehrlichia canis/chaffeensis 0 381 0 60 0 84 0 30
B. burgdorferi (s.l.) (Bbsl) (C6) 0 381 0 60 0 84 0 30
Dirofilaria immitis 0 381 0 60 0 84 0 30
Abbreviations: Neg negative, Pos positive
Table 3 Kinetic ELISA serology test results
KELA value (units) Number Interpretation
0–99.9 431 negative
100–199.9 118 positive
200–299.9 4
> 300 1
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A total of 123 dogs (22.2%) were positive by ELISA
(KELA units > 100; Table 3). One dog with a strong posi-
tive serological test result (KELA units = 399.4) had lived in
the USA and information provided by the owner indicated
this individual had been vaccinated against B. burgdorferi
(s.s.) before travelling to Australia. As it was considered this
titre was induced by vaccination, data from this dog were
removed prior to further statistical analysis.
There was no sex predilection for antibodies with
24% of male dogs compared with 18% of females
positive (P = 0.099) (Table 4). Slightly more dogs with
a history of previous tick attachment (23.1%) were
positive than those without a history of tick attach-
ment (20.4%) and dogs that were positive were signifi-
cantly older (6.5 years) than negative dogs (5.4 years)
(F(1,513) = 6.7, P = 0.010). A higher percentage of dogs
with a history of tick paralysis, implying prolonged at-
tachment of Ixodes holocyclus, were positive (29.5%)
compared with dogs without a history of tick paralysis
(17.4%) (P = 0.002). The odds of positivity in dogs
with tick paralysis was twice that of dogs without this
specific history (Table 4). Neither a history of ectoparasiti-
cide application (χ2 = 0.871, df = 1, P = 0.351) nor previous
exposure to fleas (χ2 = 0.009, df = 1, P = 0.926) was signifi-
cantly associated with seropositivity. Additionally, there
was no significant association between the Borrelia-specific
antibody levels (KELA units) and location as assessed by
postcode (χ2 = 1.186, df = 8, P = 0.997). A slightly higher
percentage of dogs with a history of travel were seropositive
(21.9%) compared with dogs without a history of travel
(14.8%) (P = 0.064); the odds of positivity in travelling dogs
was 1.6 (95% CI: 1.0–2.7) of dogs not travelling (Table 4).
There was a significant difference in seropositivity be-
tween the four groups (χ2 = 17.094, df = 3, P = 0.001); the
proportion of seropositive dogs using the ELISA was
greatest in the group with the highest exposure to I.
holocyclus ticks (Group 3 dogs used for antiserum produc-
tion), with dogs in this group 2.7 times more likely to be
positive (95% CI: 1.3–6.0) than dogs in Group 2 (Table 4).
Line immunoassay analysis revealed strong bands to
recombinant OspA and DpbA antigens in the single
vaccinated dog referred to above, and moderate-to-weak
(equivocal) bands in a small number (n = 29; 4.9%) of
other dogs. Three individuals (including the vaccinated
dog) had three bands, one dog had two bands, and 25
dogs had a single positive band on LIA.
Discussion
Canines have been identified in overseas studies to be
useful sentinels for tick-transmitted zoonotic disease
[20]. The main purpose of this study was to search for
evidence of B. burgdorferi (s.l.), the causative agents of
LB, and our results strongly suggest that these pathogens
are not present in Australia. We hypothesised that if B.
burgdorferi (s.l.), other related Borrelia species, or other
zoonotic tick-associated pathogens were present in
Australia, dogs exposed to vector ticks would develop
antibodies that would be detected by one or more of the
serological methods used in this study. Given that the
identity of an Australian vector, if present, is unknown,
we reasoned that for a locally transmitted tick-associated
zoonotic infectious disease, or group of diseases, to
become established in Australia, the tick(s) responsible
would be relatively widely distributed and well known to
attach to and feed on humans. Dogs with increased risk
of exposure to I. holocyclus were therefore targeted,
since this species parasitizes multiple vertebrate hosts,
including humans, it belongs to the genus (Ixodes) which
in the northern hemisphere is responsible for the trans-
mission of LB-causing Borrelia organisms, Anaplasma
spp. and Babesia spp. [21], and the geographical distri-
bution of I. holocyclus appears to largely coincide with
that of the LD-like cases reported in the scientific
Table 4 Details of KELA serology test results with signalment
and historical information, and odd ratios
Group Seropositive
KELA units
> 100 (n)a
Seronegative
KELA units
< 100 (n)a
Percent
positive
(95% CI)
OR (95% CI)
1 70 310 18.4 (14.7–22.7) 1.0 (0.5–2.0)
2 11 49 18.3 (9.5–30.4) 1.0
3 32 52 38.1 (27.7–49.3) 2.7 (1.3–6.0)
4 9 21 30.0 (14.7–49.4) 1.9 (0.7–5.3)
Sex
Male 67 212 24.0 (19.1–29.5) 1.4 (0.9–2.2)
Female 42 191 18.0 (13.3–23.6) 1.0
Tick history
Yes 91 303 23.1 (19.0–27.6) 1.2 (0.7–2.0)
No 20 78 20.4 (12.9–29.7) 1.0
Tick paralysis
Yes 61 146 29.5 (23.4–36.2) 2.0 (1.3–3.1)
No 49 233 17.4 (13.1–22.3) 1.0
Flea history
Yes 46 198 18.9 (14.1–24.3) 1.0 (0.6–1.8)
No 24 106 18.5 (12.2–26.2) 1.0
Ectoparasiticide use
Yes 57 242 19.1 (14.8–24.0) 1.4 (0.7–2.9)
No 10 60 14.3 (7.1–24.7) 1.0
Travel history
Yes 50 178 21.9 (16.7–27.9) 1.6 (1.0–2.7)
Stayed at
home
28 161 14.8 (10.1–20.7) 1.0
Total 122b 432 22.0 (18.6–25.7)
aData not available from every individual (some incomplete survey responses)
bOne data point (vaccinated dog) has been removed from this analysis
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literature in Australia [12]. Although there are another
18 species of Ixodes tick species described in Australia
[22], all are confined to the Australian continent; most
of these have highly restricted host ranges and/or enzo-
otic distributions, and rarely bite humans [22]. Certainly,
if I. holocyclus was responsible for the transmission of
Bbsl to animals or people in Australia, unequivocally
positive results would have been detected in the fox-
hounds comprising Group 3; it is estimated that at the
time of sampling these dogs had collectively been hosts
to approximately 160,000 female paralysis ticks and that
these ticks were representative of multiple locations
throughout the species’ enzootic range along the eastern
seaboard of Australia.
Using three different serological methods, only one
dog in the total cohort of 555 was assessed to have a
reliably positive antibody response, and this dog, an
8-year-old female Labrador, was born in the USA, vacci-
nated against LB as part of a routine vaccination
program in the USA, and travelled to Sydney, Australia
in 2009, two years prior to being sampled for this study.
Antibody levels induced by vaccination start to wane
considerably within a few weeks after immunisation but
may be detected for years [23]. This dog had the highest
KELA value by a considerable margin (>150 KELA units)
and three positive bands (very strong positive to OspA,
with additional positive bands to DbpA-mix and a
58 kDa recombinant antigen) on LIA. The outer surface
protein A (OspA) is a component of all approved LB
vaccines. Another outer protein membrane protein,
variable major protein-like sequence, expressed (VlsE)
contains antigenically variable and invariable regions.
Detection of antibody to the sixth invariable region of
the VlsE protein (a peptide known as IR6 or the shorter
synthetic version C6) has become a reliable serological
marker for the diagnosis of LB and is incorporated into
the rapid EIA used in this study. However, genes for the
C6 peptide are only expressed during replication of Bbsl
bacteria in the mammalian host, and this peptide is not
incorporated into LB vaccines [24]. Unsurprisingly,
therefore, the vaccinated dog described above was nega-
tive to the C6 antigen, and this result further indicated
that no natural exposure to Bbsl had occurred in this
individual.
Our data indicate that the prevalence of vector-borne
infections, as determined by serological responses to a
panel of antigens, was very low in the study groups. To
some extent this result is unsurprising, since only A.
platys, Babesia vogeli and canine haemoplasmas are re-
ported to be transmitted to dogs by ticks in Australia,
and each of these is vectored by the brown dog tick (R.
sanguineus) [25]. Except for dogs in Group 4, the major-
ity of individuals tested in the current study lived in
southern and south-eastern regions of Australia where
R. sanguineus is relatively uncommon; dogs in these
temperate areas are much more likely to be bitten by I.
holocyclus or the cattle tick Haemaphysalis longicornis,
neither of which is known to vector the pathogens men-
tioned above [26]. Furthermore, Australia is currently
considered by veterinary authorities to be free from A.
phagocytophilum, E. canis (and E. chaffeensis), and mem-
bers of the B. burgdorferi (s.l.) complex [27]. The single
positive result to Anaplasma spp. with the rapid EIA
testing could have represented an antibody response to
A. platys, A. phagocytophilum, or a false positive result.
One likely explanation that despite living in Sydney and
returning a negative PCR result, this dog was at some
previous time been bitten by R. sanguineus with the sub-
sequent transmission of A. platys. This organism causes
canine infectious cyclic thrombocytopenia which in most
cases results in only mild illness if any. The owners
reported prior tick bite (and tick paralysis) in this dog,
but information on the identity of ticks on this dog
(other than I. holocyclus) was not available. The absence
of positive antibody results to A. platys in dogs in Group
4 was, however, unexpected since these dogs were regu-
larly bitten by R. sanguineus, and the prevalence of this
pathogen in rural Indigenous communities has been
reported previously to be as high as 32% [28]. The
absence of heartworm (D. immitis) antigen in any of the
dogs tested is interesting and is in line with recent
unpublished reports of an overall decrease in prevalence
throughout Australia as a result of high uptake of heart-
worm prophylaxis medication [29].
In contrast to the rapid EIA results, approximately
23% of the dogs tested in this study were weakly positive
(between 100 and 299.9 units) using the kinetic ELISA
(KELA) with a solid phase antigenic substrate derived
from whole, cultured B. burgdorferi (s.s.) organisms. This
ELISA is a sensitive test yet has poor specificity espe-
cially for equivocal canine serum samples (100–200
KELA units) [18]. The possible explanations for a positive
result in this assay include exposure to the B. burgdorferi
(s.l.) genogroup; exposure to another Borrelia species (or
group), either introduced or endemic to Australia; or
cross-reactivity with antigens from other bacteria of
unknown identity. The latter two explanations represent
false positive results. As noted above, the absence of any
sample testing positive for the C6 antigen strongly miti-
gates against the exposure to Bbsl in the dogs tested and
furthermore, the absence of specific band patterns in the
LIA results also reduces the likelihood of Bbsl exposure in
this cohort. We believe another reason must be consid-
ered to explain this result.
Other Borrelia species are known to exist in Australia
(reviewed in [12]). Two species of the genus Borrelia, B.
theileri and B. anserina (relapsing fever spirochetes),
were introduced to the continent by cattle and poultry,
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respectively, and their vector ticks, during the establish-
ment and development of the Australian agricultural in-
dustry since European settlement in 1788. Despite this,
borreliosis in the form of relapsing fever in these domes-
ticated animals is seldom diagnosed in Australia and is
of relatively little economic impact. The species neither
belong to the B. burgdorferi (s.l.) (Bbsl) complex (respon-
sible for LB) nor (of more relevance with regard to sero-
logical testing) do the ticks responsible for their
transmission, R. (Boophilus) australis and Argas persicus,
respectively, bite people or dogs with any great fre-
quency [22]. Questions about the presence of native
Borrelia species, endemic to the Australian continent
and therefore (presumably) maintained in sylvatic life-
cycles, are largely unanswered at the present time. Spiro-
chaetes were reported in marsupials and native rodents
[30, 31] long before any molecular testing was available
to reliably identify them, and the vectors of these organ-
isms (if any) are unknown. Very recently DNA of novel
Borrelia spp. has been amplified from a single I. holocyclus
tick and from 39% Bothriocroton concolor ticks (n =
97) feeding on echidnas (Tachyglossus aculeatus), a
monotreme, in eastern Australia [32, 33]. Phylogenetic
analysis has revealed this Borrelia species to exist in
its own clade, distinct from the LB, Relapsing Fever
and Reptile-associated Borrelia clades, and possibly
represents a grouping that is unique to Australia.
Nothing is known yet about its biology or whether it
can be transmitted to other animals, including
humans, but this seems unlikely given that B. concolor
is a specialist tick that feeds only from echidnas [22].
Next generation DNA sequencing of large numbers of I.
holocyclus removed from a wide variety of hosts has, to
date, failed to detect any more individual ticks infected
with this organism [32, 34]. It seems unlikely therefore
that the positive results in the kinetic ELISA test are due
to an as yet unidentified Borrelia species in Australia.
It is intriguing that the prevalence of KELA seroposi-
tivity was higher in dogs with the greatest tick exposure
(Groups 3 and 4) and that there was a significant associ-
ation between seropositivity and tick paralysis, with
foxhounds (Group 3) 2.7 times more likely to be sero-
positive than the dogs in Groups 1 and 2, suggesting a
strong relationship between seropositivity and a clinic-
ally significant association with I. holocyclus. The inter-
val between tick attachment and the development of
neurological signs seems to be variable between individ-
uals (and was actually absent in the foxhounds due to
their tolerance of the venom) but generally develops
between 4 and 5 days after attachment [35]. Regardless,
it is plausible that infectious organisms, a potential
source for cross-reacting antibodies in our ELISA, may
be transmitted from the salivary glands (or midgut) at
the same time that venom is injected once the tick is
attached to the host. The possible identity of these infec-
tious organisms remains unknown at the present time
and is a subject that requires urgent investigation due to
its potential to mislead diagnosis. One of the most con-
tentious issues pertaining to the current LB debate in
Australia pertains to the detection of antibodies against
Borrelia spp. (and other pathogens including Anaplasma
spp., Ehrlichia spp. and Babesia spp., for example) by
laboratories testing serum from people who have never
travelled outside Australia. We have conducted similar
testing protocols in this study, applied to dogs and utiliz-
ing antigens and serological tests that have been developed
for known pathogens in the northern hemisphere. Our
interpretation of our dogs’ serology, based largely on the ab-
sence of reactivity to the C6 antigen and the absence of
robust bands by line immunoassay, is that (1) the seroreac-
tivity in nearly a quarter of the dogs tested, especially in
those with tick exposure, represents cross-reactivity with
antigens of as yet unidentified microorganism(s), (2) LB is
an inappropriate diagnosis to make, and (3) appropriate
diagnostic tools need to be applied. Furthermore, the
microorganism(s) responsible for engendering this antibody
response do not appear to be confined to I. holocyclus since
our control group (Group 4), ostensibly included as a group
with no possible exposure to paralysis ticks, yet with high
tick exposure (to R. sanguineus), also returned positive
results in 30% individuals.
Conclusions
We conclude that vector-borne infections with the path-
ogens tested in this study were extremely uncommon.
Except for a single dog presumed to have been exposed
to Anaplasma platys, infection with Anaplasma spp.
Borrelia burgdorferi (s.l.), Ehrlichia spp. and Dirofilaria
immitis, was not detected. We, therefore, propose that
these results provide further evidence that Lyme borreliosis
does not exist in Australia but that cross-reacting anti-
bodies (false positive results), as determined in this study by
KELA unit value > 100, are common and may be caused by
the transmission of other tick-associated organisms.
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